Apollomics (APLM) Common Equity (2021 - 2025)

Apollomics (APLM) has reported Common Equity for 5 consecutive years, with -$275000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Common Equity fell 109.59% year-over-year to -$275000.0 in Q4 2025; TTM through Dec 2025 was -$275000.0, a 109.59% decrease from a year earlier, with the FY2025 full-year figure at -$275000.0, down 109.59% from the prior year.
• Common Equity was -$275000.0 for Q4 2025 at Apollomics, up from -$343000.0 in the prior quarter.
• Over five years, Common Equity peaked at $55.7 million in Q2 2023 and troughed at -$448.1 million in Q4 2022.
• A 5-year average of -$83.7 million and a median of -$275000.0 in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity sank 110.52% in 2022 and jumped 126.21% in 2023, its largest moves.
• Over 5 years, Common Equity stood at -$212.9 million in 2021, then slumped by 110.52% to -$448.1 million in 2022, then jumped by 109.2% to $41.2 million in 2023, then plunged by 93.04% to $2.9 million in 2024, then sank by 109.59% to -$275000.0 in 2025.
• The last three Common Equity figures came in at -$275000.0 (Q4 2025), -$343000.0 (Q2 2025), and $2.9 million (Q4 2024), per Business Quant data.